Correlation between decrease of CRP and resolution of airway inflammatory response, improvement of health status, and clinical outcomes during severe acute exacerbation of chronic obstructive pulmonary disease
- 31 March 2015
- journal article
- Published by Springer Science and Business Media LLC in Internal and Emergency Medicine
- Vol. 10 (6), 685-691
- https://doi.org/10.1007/s11739-015-1228-2
Abstract
Circulating C-reactive protein (CRP) plays an important role in mediating extra-pulmonary complications of chronic obstructive pulmonary disease (COPD). The aim of this study was to investigate the relationship between changes in high sensitivity (hs)-CRP levels and the resolution of airway inflammatory markers and clinical health status during the recovery period after an acute exacerbation of COPD (AECOPD). Consecutive patients hospitalized for AECOPD were recruited. Serum hs-CRP, airway inflammatory markers, and COPD Assessment Test (CAT) score were evaluated at admission prior to treatment and at days 4, 7, and 14. Adverse outcomes were recorded. The relationship between changes in airway inflammatory markers, CAT score, and hs-CRP during the recovery period was studied. A total of 135 patients were enrolled. Serum hs-CRP levels at admission of patients with adverse outcomes were marginally higher than those without an adverse outcome (7.6 [4.8, 16.7] vs. 6.6 [4.7, 9.3], p = 0.061). Compared with patients without cardiovascular complications, patients with cardiovascular complications had higher serum hs-CRP levels at admission (11.6 [6.7, 16.7] vs. 6.6 [4.4, 10.0], p = 0.001). Sputum neutrophils were positively correlated to hs-CRP at admission (r = 0.474, p < 0.001). A decreasing hs-CRP level was positively related to decreasing sputum neutrophils at day 4 and 7 (r = 0.455, p < 0.001; r = 0.504, p < 0.001, respectively). Significant correlations between decreasing hs-CRP and CAT at all time-points were noted. Hs-CRP may be useful in monitoring airway inflammation resolution and improvement of health status during AECOPD treatment.Keywords
This publication has 36 references indexed in Scilit:
- Increased Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease and the Potential Mechanisms Linking the Two ConditionsCardiology in Review, 2013
- Inflammatory Biomarkers and Comorbidities in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countriesInternational Journal of Chronic Obstructive Pulmonary Disease, 2012
- Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to Evaluate Severity of COPD ExacerbationsAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2010
- C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbationsCurrent Opinion in Pulmonary Medicine, 2009
- C‐reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary diseaseRespirology, 2008
- Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary diseaseClinical Science, 2008
- The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD)Primary Care Respiratory Journal, 2007
- C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary diseaseThorax, 2006